EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Resveratrol as an Adjunct Antiviral Agent in Pediatric Viral Infections: A Review on Mechanistic Insights and Gut Microbiota Modulation

Roberta Leonardi iD, Manuela Lo Bianco iD, Salvatore Spinello iD, Pasqua Betta iD, Caterina Gagliano iD, Vittorio Calabrese iD, Agata Polizzi iD, Giulia Malaguarnera iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311341 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Roberta Leonardi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Training Programme in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Resveratrol, Gastrointestinal Microbiome, Antiviral Agents, Virus Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric viral infections impose a heavy burden on child health, often worsened by infection-induced gut dysbiosis. Resveratrol, a natural polyphenol with antiviral, anti-inflammatory, and microbiota-modulating properties, has been proposed to interrupt this pathogenic feedback. To our knowledge, this is the first narrative review focused on resveratrol’s antiviral activity in pediatric viral infections, concurrently evaluating its impact on the gut microbiota and their interrelationship. We synthetized preclinical and the limited available pediatric clinical data regarding resveratrol’s effect on SARS-CoV-2, respiratory syncytial virus, influenza, rotavirus, and norovirus, extracting information on the models, routes of administration, dosages, mechanisms, and outcomes. Resveratrol interferes with viral lifecycles via diverse mechanisms (modulation of host signaling cascades, capsid or structural protein interactions, and suppression of pro-viral chaperones) while concurrently reshaping the gut microbiota (reducing opportunistic taxa and enriching beneficial genera such as Bifidobacterium and Lactobacillus) leading to improved short-chain fatty acid profiles, barrier integrity, and dampened inflammation. Intranasal resveratrol in children shows clinical benefit, while oral use is underexplored and limited by poor bioavailability; adult data hint at supportive microbiome and anti-inflammatory effects if the delivery is optimized. These dual antiviral and microbiome-directed effects position resveratrol as a promising adjunct in pediatric viral disease management, though well-powered pediatric clinical trials are needed to define dosages, delivery strategies, and the contribution of microbiota-mediated synergy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolGastrointestinal MicrobiomeAntiviral AgentsVirus DiseasesHumansChildSARS-CoV-2DysbiosisCOVID-19Rotavirus

Stichwörter der Autor:innen

antiviral mechanismsdysbiosisgut microbiotapediatric viral infectionsresveratrol

Substanzen

ResveratrolAntiviral Agents

Autor:innen und Institutionen

  • Postgraduate Training Programme in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
  • Neonatal Intensive Care Unit, AOU Policlinico G. Rodolico San Marco, 95123 Catania, Italy.
  • Unit of Pediatric Clinic, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
  • Federazione Italiana Medici di Medicina Generale-F.I.M.M.G. (Italian Federation of General Practitioners), 00153 Rome, Italy.
  • Department of Medicine and Surgery, University of Enna "Kore", Piazza dell'Università, 94100 Enna, Italy.
  • Eye Center G.B. Morgagni-DSV, 95125 Catania, Italy.

ORCID-Profile: Roberta Leonardi, Manuela Lo Bianco, Salvatore Spinello, Pasqua Betta, Caterina Gagliano, Vittorio Calabrese, Agata Polizzi, Giulia Malaguarnera

Zitieren

APA

Leonardi, R., Lo Bianco, M., Spinello, S., Betta, P., Gagliano, C., Calabrese, V., Polizzi, A., & Malaguarnera, G. (2025). Resveratrol as an Adjunct Antiviral Agent in Pediatric Viral Infections: A Review on Mechanistic Insights and Gut Microbiota Modulation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311341

Vancouver

Leonardi R, Lo Bianco M, Spinello S, Betta P, Gagliano C, Calabrese V, et al. Resveratrol as an Adjunct Antiviral Agent in Pediatric Viral Infections: A Review on Mechanistic Insights and Gut Microbiota Modulation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311341

BibTeX
@article{Leonardi2025,
  author = {Leonardi, Roberta and Lo Bianco, Manuela and Spinello, Salvatore and Betta, Pasqua and Gagliano, Caterina and Calabrese, Vittorio and Polizzi, Agata and Malaguarnera, Giulia},
  title = {Resveratrol as an Adjunct Antiviral Agent in Pediatric Viral Infections: A Review on Mechanistic Insights and Gut Microbiota Modulation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311341}
}
Kostenlos starten →